全文获取类型
收费全文 | 6399篇 |
免费 | 690篇 |
国内免费 | 246篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 207篇 |
妇产科学 | 61篇 |
基础医学 | 2181篇 |
口腔科学 | 102篇 |
临床医学 | 438篇 |
内科学 | 1103篇 |
皮肤病学 | 178篇 |
神经病学 | 499篇 |
特种医学 | 52篇 |
外国民族医学 | 2篇 |
外科学 | 243篇 |
综合类 | 542篇 |
现状与发展 | 1篇 |
预防医学 | 207篇 |
眼科学 | 69篇 |
药学 | 614篇 |
1篇 | |
中国医学 | 201篇 |
肿瘤学 | 615篇 |
出版年
2024年 | 13篇 |
2023年 | 162篇 |
2022年 | 171篇 |
2021年 | 230篇 |
2020年 | 267篇 |
2019年 | 272篇 |
2018年 | 247篇 |
2017年 | 265篇 |
2016年 | 260篇 |
2015年 | 243篇 |
2014年 | 332篇 |
2013年 | 540篇 |
2012年 | 268篇 |
2011年 | 316篇 |
2010年 | 262篇 |
2009年 | 270篇 |
2008年 | 255篇 |
2007年 | 278篇 |
2006年 | 286篇 |
2005年 | 227篇 |
2004年 | 239篇 |
2003年 | 196篇 |
2002年 | 196篇 |
2001年 | 174篇 |
2000年 | 152篇 |
1999年 | 126篇 |
1998年 | 124篇 |
1997年 | 107篇 |
1996年 | 114篇 |
1995年 | 85篇 |
1994年 | 71篇 |
1993年 | 66篇 |
1992年 | 53篇 |
1991年 | 42篇 |
1990年 | 56篇 |
1989年 | 40篇 |
1988年 | 29篇 |
1987年 | 32篇 |
1986年 | 30篇 |
1985年 | 60篇 |
1984年 | 35篇 |
1983年 | 26篇 |
1982年 | 39篇 |
1981年 | 21篇 |
1980年 | 15篇 |
1979年 | 12篇 |
1978年 | 14篇 |
1977年 | 9篇 |
1976年 | 5篇 |
1971年 | 1篇 |
排序方式: 共有7335条查询结果,搜索用时 15 毫秒
1.
《Mayo Clinic proceedings. Mayo Clinic》2019,94(7):1321-1329
Immune checkpoint inhibitors are molecules that increase the endogenous immune response against tumors. They have revolutionized the field of oncology. Since their initial approval for the treatment of advanced melanoma, their use has expanded to the treatment of several other advanced cancers. Unfortunately, immune checkpoint inhibitors have also been associated with the emergence of a new subset of autoimmune-like toxicities, known as immune-related adverse events. These toxicities differ depending on the agent, malignancy, and individual susceptibilities. Although the skin and colon are most commonly involved, any organ may be affected, including the liver, lungs, kidneys, and heart. Most of these toxicities are diagnosed by excluding other secondary infectious or inflammatory causes. Corticosteroids are commonly used for treatment of moderate and severe immune-related adverse events, although additional immunosuppressive therapy may occasionally be required. The occurrence of immune-related toxicities may require discontinuation of immunotherapy, depending on the specific toxicity and its severity. In this article, we provide a focused review to familiarize practicing clinicians with this important topic given that the use of immune checkpoint inhibitors continues to increase. 相似文献
2.
3.
Nandita M deSouza Clare M Tempany 《International journal of cancer. Journal international du cancer》2019,144(3):422-430
Recognition of <3 metastases in <2 organs, particularly in cancers with a known predisposition to oligometastatic disease (OMD) (colorectal, prostate, renal, sarcoma and lung), offers the opportunity to focally treat the lesions identified and confers a survival advantage. The reliability with which OMD is identified depends on the sensitivity of the imaging technique used for detection and may be predicted from phenotypic and genetic factors of the primary tumour, which determine metastatic risk. Whole-body or organ-specific imaging to identify oligometastases requires optimization to achieve maximal sensitivity. Metastatic lesions at multiple locations may require a variety of imaging modalities for best visualisation because the optimal image contrast is determined by tumour biology. Newer imaging techniques used for this purpose require validation. Additionally, rationalisation of imaging strategies is needed, particularly with regard to timing of imaging and follow-up studies. This article reviews the current evidence for the use of imaging for recognising OMD and proposes a risk-based roadmap for identifying patients with true OMD, or at risk of metastatic disease likely to be OM. 相似文献
4.
5.
目的从三列凹顶藻Laurenciatristicha中寻找具有多样性结构的倍半萜化学成分,供药理活性筛选。方法采用凝胶柱色谱、硅胶柱色谱、重结晶和高效液相色谱等方法进行分离;借助包括一维和二维NMR等波谱方法和X-单晶衍射鉴定化合物的结构;用MTT法对得到的化合物进行细胞毒活性评价。结果分离得到5个倍半萜类化合物,分别鉴定为海兔阿普里素(aplysin,)、海兔阿普里醇(aplysinol,)、去溴海兔阿普里醇(debro-moaplysinol,)、凹顶藻联苯(laurebiphenyl,)、约翰斯顿醇(johnstonol,);在人肿瘤细胞株HCT-8、Bel-7402、BGc-823、A549和HeLa模型上,化合物对所有细胞株均显示毒性,化合物对HeLa细胞显示中等强度的细胞毒活性,其他化合物对所有细胞株均无明显毒性,IC50均大于10.0μg/mL。结论化合物~均为首次从三列凹顶藻中得到,化合物对HeLa细胞具有中等强度的选择性细胞毒活性,化合物对所有细胞株均显示毒性。 相似文献
6.
目的:探讨增殖性肾小球肾炎大鼠动物模型中系膜细胞α-平滑肌肌动蛋白(α-SMA)表达与细胞表型的关系。方法:应用单克隆抗体1-22-3(MoAb1-22-3)及Habu蛇毒素分别诱导大鼠增殖性肾小球肾炎动物模型。用免疫组化技术并结合计算机图像分析,检测两个不同诱因引起模型的各个阶段的系膜细胞内α-平滑肌肌动蛋白,SMeb的表达程度,系膜细胞增殖和细胞外基质(ECM)分泌的情况。结果:在MoAb1-22-3模型,随着系膜细胞增殖程度的加理,ECM积聚增多,α-SMA的表达程度也增加,三者平行变化并具有高度相关性,而Habu模型则系膜细胞增殖和ECM增加的同时α-SMA,SMemb表达不增加。结论:α-SMA不是系膜细胞被激活并处于增殖/分泌表型唯一标志。 相似文献
7.
转化人关节软骨细胞的Ⅱ型胶原表型诱导 总被引:1,自引:0,他引:1
目的 用离心管聚集体培养(Aggregate culture)诱导转化人关节细胞的Ⅱ型胶原。方法 将体外长期培养的第30,40,50代转化软骨细胞消化后进行离心管培养,比较细胞在单层培养,离心管聚集体培养,以及在普通培养基,RAI诱导培养基下[2型骨形态发生蛋白(BMP-2)+抗坏血酸盐(Ascorbate) 胰岛素(insulin)],Ⅰ,Ⅱ,Ⅲ型胶原的表达和胞外基质发生情况。结果 在单层培养条件下,转化软骨细胞只表达Ⅰ型胶原,而在BAI诱导培养基及离心管聚集体培养下转化软有细胞表达的Ⅱ型胶原和大量胞外基质。结论 离心管聚集体培养是诱导转化软骨细胞Ⅱ型胶原的有效方式。 相似文献
8.
采集23名产妇的脐带血和8名正常成人的外周血制备LAK细胞,随机分为4组,在培养第3,5,7,14天,分别利用MTT法和^125I-UdR释放法对4组LAK细胞的增殖力和杀伤活性进行了测定,同时用细胞毒方法测定培养7天的LAK细胞的免疫表型。结果发现,在不同培养时间,脐血来源的LAK细胞增殖力显著高于成人血LAK细胞(P〈0.05或P〈0.01),成人血清组,脐血血清组,红细胞组LAK细胞增殖力有 相似文献
9.
Uta Lichter-Konecki Christian Benninger Werner E. Brandeis Peter Matthis Dieter Scheffner 《Pediatric hematology and oncology》1987,4(1):77-85
Thirteen children with acute lymphoblastic leukemia (ALL) were investigated before and during cytotoxic therapy. EEG findings were correlated with the clinical course and the therapy protocol and compared with normal data obtained from 295 healthy children. Frequency analysis of the background activity of the EEG revealed an initial slowing of the background activity prior to therapy and further slowing each time a combination of vincristine (VCR), daunorubicine (DAU) or adriblastine (ADR), prednisone (FRED), and L-asparaginase (L-ASP) was administered. The slowing of the background activity correlated only with the administration of these drugs. DAU, ADR, and FRED are not known to influence the EEG; therefore, VCR and L-ASP remain the primary candidates responsible for the central nervous system alteration. 相似文献
10.
Gabriele Masi Giulio Perugi Cristina Toni Stefania Millepiedi Maria Mucci Nicoletta Bertini Hagop S Akiskal 《Neuropsychopharmacology》2006,59(7):603-610
BACKGROUND: Recent research has addressed the issue of subtyping juvenile bipolar disorder (JBD). Accordingly, we set out to find out, in a naturalistic sample of bipolar children and adolescents with mania and mixed mania, whether the most useful subtyping should be based on clinical features (elated vs. irritable) or course (episodic vs. chronic). METHODS: We studied 136 patients, 81 male patients (59.6%) and 55 female patients (40.4%), mean age 13.5 +/- 2.9 years, meeting the DSM-IV diagnosis of bipolar disorder, assessed by a structured clinical interview (Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version [K-SADS-PL]). RESULTS: Regarding course, 77 patients (56.6%) had an episodic course and 59 patients (43.4%) had a chronic course. Patients with chronic course were significantly younger, had an earlier onset of JBD, and presented a more frequent comorbidity with disruptive behavior disorders. According to the prevalent mood disturbance, 75 patients (55.1%) showed an elated and 61 patients (44.9%) showed an irritable mood. Elated mood was more frequent in patients with episodic course, whereas irritable mood was more frequent in the patients with chronic course. CONCLUSIONS: These findings suggest that chronic versus episodic course may be a putative differential feature. Further validation of such a distinction would require prospective studies, temperament evaluation, gender and neurobiologic approaches, and differential psychopharmacologic assignment and response. 相似文献